» Articles » PMID: 26912672

The Multifactorial Nature of MicroRNAs in Vascular Remodelling

Overview
Journal Cardiovasc Res
Date 2016 Feb 26
PMID 26912672
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular remodelling is a multifactorial process that involves both adaptive and maladaptive changes of the vessel wall through, among others, cell proliferation and migration, but also apoptosis and necrosis of the various cell types in the vessel wall. Vascular remodelling can be beneficial, e.g. during neovascularization after ischaemia, as well as pathological, e.g. during atherosclerosis and aneurysm formation. In recent years, it has become clear that microRNAs are able to target many genes that are involved in vascular remodelling processes and either can promote or inhibit structural changes of the vessel wall. Since many different processes of vascular remodelling are regulated by similar mechanisms and factors, both positive and negative vascular remodelling can be affected by the same microRNAs. A large number of microRNAs has been linked to various aspects of vascular remodelling and indeed, several of these microRNAs regulate multiple vascular remodelling processes, including both the adaptive processes angiogenesis and arteriogenesis as well as maladaptive processes of atherosclerosis, restenosis and aneurysm formation. Here, we discuss the multifactorial role of microRNAs and microRNA clusters that were reported to play a role in multiple forms of vascular remodelling and are clearly linked to cardiovascular disease (CVD). The microRNAs reviewed are miR-126, miR-155 and the microRNA gene clusters 17-92, 23/24/27, 143/145 and 14q32. Understanding the contribution of these microRNAs to the entire spectrum of vascular remodelling processes is important, especially as these microRNAs may have great potential as therapeutic targets for treatment of various CVDs.

Citing Articles

The key role of miR‑378 in kidney diseases (Review).

Liu Y, Shi S, Cheng T, Wang H, Wang H, Hu Y Mol Med Rep. 2025; 31(4).

PMID: 39981929 PMC: 11868772. DOI: 10.3892/mmr.2025.13466.


Integrative Multi-Omics Approach in Vascular Ehlers-Danlos Syndrome: Further Insights into the Disease Mechanisms by Proteomic Analysis of Patient Dermal Fibroblasts.

Chiarelli N, Cinquina V, Zoppi N, Bertini V, Maddaluno M, De Leonibus C Biomedicines. 2025; 12(12.

PMID: 39767655 PMC: 11727028. DOI: 10.3390/biomedicines12122749.


MicroRNA expression alteration in chronic thromboembolic pulmonary hypertension: A systematic review.

Sulastomo H, Dinarti L, Hariawan H, Haryana S Pulm Circ. 2024; 14(3):e12443.

PMID: 39308943 PMC: 11413763. DOI: 10.1002/pul2.12443.


MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension-A Systematic Review.

Kondracki B, Kloda M, Jusiak-Kloda A, Kondracka A, Wacinski J, Wacinski P Int J Mol Sci. 2024; 25(12).

PMID: 38928136 PMC: 11204345. DOI: 10.3390/ijms25126430.


The Intriguing World of Vascular Remodeling, Angiogenesis, and Arteriogenesis.

Quax P, Deindl E Int J Mol Sci. 2024; 25(12).

PMID: 38928082 PMC: 11204171. DOI: 10.3390/ijms25126376.